AIA
GSK icon

Allegis Investment Advisors’s GSK GSK Stock Holding History

Allegis Investment Advisors’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-18,929
Closed -$959K – 198
2016
Q1 		$959K Buy
18,929
+2,954
+18% +$147K 0.55% 69
2015
Q4 		$806K Buy
+15,975
New +$814K 0.45% 63

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Allegis Investment Advisors's GSK Position: Q2 2016 in Review

Allegis Investment Advisors sold out of GSK (GSK) in Q2 2016, closing a stake of 18,929 shares — an estimated $959K sold.

Allegis Investment Advisors first reported a position in GSK in Q4 2015 and held it in 2 quarters. The position peaked at $959K in Q1 2016. 741 funds tracked by Wall St. Rank hold GSK as of Q2 2016.

  • Allegis Investment Advisors reported no remaining GSK position as of Q2 2016 after selling out during the quarter.
  • Allegis Investment Advisors sold 18,929 GSK shares in Q2 2016, an estimated $959K.
  • Allegis Investment Advisors first reported a position in GSK in Q4 2015 and held it in 2 quarters.
  • Allegis Investment Advisors's GSK position peaked at $959K in Q1 2016.
  • 741 funds tracked by Wall St. Rank held GSK as of Q2 2016.

Based on Allegis Investment Advisors's 13F filing for Q2 2016, filed 8 Aug 2016.